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Background: Peri-stent contrast staining (PSS) has been recognized as a predictor for very late stent thrombosis after sirolimus-eluting stent 
(SES) implantation. However, the pathogenesis of PSS remains poorly understood. We analyzed tissue characterization of target plaque before SES 
implantation and determined the impact of plaque characterization on subsequent development of PSS.
methods: This study consisted of 138 consecutive patients who were treated with SES. For all stented segments, development of PSS was assessed 
by follow-up angiography within 24 months after stent implantation. PSS was defined as contrast staining outside the stent contour extending to 
more than 20% of the stent diameter on follow-up angiography. Volumetric tissue characterization analysis by integrated backscatter intravascular 
ultrasound was performed for target plaque before SES implantation. The percentage of each plaque component (lipid, fibrous and calcification) was 
compared between lesions with and without subsequent PSS.
results: Of 138 patients, development of PSS was identified in 9 patients (6.5%). In lesions with subsequent PSS, the percentage of lipid volume 
was significantly increased and the percentage of fibrous volume was significantly decreased compared to those without PSS (Lipid: 42.6% ± 10.7% 
vs. 32.3% ± 13.2%; p=0.02, Fibrous: 52.9% ± 7.2% vs. 61.7% ± 11.2%; p=0.01). Multivariable logistic regression analysis identified the lipid rich 
plaque, defined as the highest tertile of the percentage of lipid plaque volume, as an independent predictor of subsequent PSS (odds ratio 11.7; 
p=0.007).
conclusions: Lipid rich plaque is an independent predictor of subsequent peri-stent contrast staining after SES implantation.
